Bullous pemphigoid antigen 1 isoforms: Potential new target autoantigens in multiple sclerosis?

British Journal of Dermatology

Volumn 152, Issue 3, 2005, Pages 537-540

  Laffitte, Emmanuel ^a,b   Burkhard, P R ^a   Fontao, L ^a   Jaunin, F ^a   Saurat, J H ^a   Chofflon, M ^a   Borradori, L ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Autoantibody; Bullous pemphigoid; Bullous pemphigoid antigen 1; Dystonin; Epitope spreading phenomenon; Multiple sclerosis

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; BULLOUS PEMPHIGOID ANTIGEN 1; GLUTATHIONE TRANSFERASE;

ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNE DISEASE; BPAG1 GENE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; GENE; HUMAN; IMMUNOBLOTTING; MULTIPLE SCLEROSIS; NERVE CELL; NEUROLOGIC DISEASE; PEMPHIGOID; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; SCHWANN CELL; SKIN;

AUTOANTIBODIES; AUTOANTIGENS; CARRIER PROTEINS; CYTOSKELETAL PROTEINS; GLUTATHIONE TRANSFERASE; HUMANS; MULTIPLE SCLEROSIS; NERVE TISSUE PROTEINS; PEMPHIGOID, BULLOUS; PROTEIN ISOFORMS; RECOMBINANT PROTEINS;

EID: 17444381948     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.06338.x     Document Type: Article

References (21)

1. Stanley JR, Tanaka T, Mueller S et al. Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies. J Clin Invest 1988; 82:1864-70.
2. Ruhrberg C, Watt FM. The plakin family: versatile organizers of cytoskeletal architecture. Curr Opin Genet Dev 1997; 7:392-7.
3. Simjee S, Konqui A, Razzaque Ahmed A. Multiple sclerosis and bullous pemphigoid. Dermotologica 1985; 170:86-9.
4. Kirtschig G, Walkden VM, Venning VA, Wojnarowska F. Bullous pemphigoid and multiple sclerosis: a report of three cases and review of the literature. Clin Exp Dermatol 1995; 20:449-53.
5. Archelos JJ, Storch MK, Hartung HP. The role of B cells and autoantibodies in multiple sclerosis. Ann Neurol 2000; 47:694-706.
6. Brown A, Dalpe G, Mathieu M, Kothary R. Cloning and characterization of the neural isoforms of human dystonin. Genomics 1995; 29:777-80.
7. Bernier G, De Repentigny Y, Mathieu M et al. Dystonin is an essential component of the Schwann cell cytoskeleton at the time of myelination. Development 1998; 125:2135-48.
8. Leung CL, Zheng M, Prater SM, Liem RK. The BPAG1 locus: alternative splicing produces multiple isoforms with distinct cytoskeletal linker domains, including predominant isoforms in neurons and muscles. J Cell Biol 2001; 154:691-7.
9. Wynn DR, Rodriguez M, O'Fallon WM et al. Update on the epidemiology of multiple sclerosis. Mayo Clin Proc 1989; 64:808-17.
10. McCoubrie M, Shuttleworth D. Prevalence of multiple sclerosis in West Yorkshire. BMJ 1978; ii:570.
11. Fox CM, Bensa S, Bray I et al. The epidemiology of multiple sclerosis in Devon: a comparison of the new and old classification criteria. J Neurol Neurosurg Psychiatry 2004; 75:56-60.
12. Guo L, Degenstein L, Dowling J et al. Gene targeting of BPAG1: abnormalities in mechanical strength and cell migration in stratified epithelia and neurologic degeneration. Cell 1995; 81:233-43.
13. Brown A, Bernier G, Mathieu M et al. The mouse dystonia musculorum gene is a neural isoform of bullous pemphigoid antigen 1. Nat Genet 1995; 10:301-6.
14. Bernier G, Brown A, Dalpe G et al. Dystonin expression in the developing nervous system predominates in the neurons that degenerate in dystonia musculorum mutant mice. Mol Cell Neurosci 1995; 6:509-20.
15. Saulnier R, De Repentigny Y, Yong VW, Kothary R. Alterations in myelination in the central nervous system of dystonia musculorum mice. J Neurosci Res 2002; 69:233-42.
16. Yang Y, Dowling J, Yu QC et al. An essential cytoskeletal linker protein connecting actin microfilaments to intermediate filaments. Cell 1996; 86:655-65.
17. Yang Y, Bauer C, Strasser G et al. Integrators of the cytoskeleton that stabilize microtubules. Cell 1999; 98:229-38.
18. Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13:227-31.
19. Favre B, Fontao L, Koster J et al. The hemidesmosomal protein bullous pemphigoid antigen 1 and the integrin beta 4 subunit bind to ERBIN. Molecular cloning of multiple alternative splice variants of ERBIN and analysis of their tissue expression. J Biol Chem 2001; 276:32427-36.
20. Laffitte E, Shafaatian R, Fontao L et al. Production of the bullous pemphigoid antigen 230 (BP230) by Saccharomyces cerevisiae and Pichia pastoris. Prot Expr Purif 2003; 29:141-7.
21. Vanderlugt CL, Miller SD. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat Rev Immunol 2002; 2:85-95.